Type 2 Inflammatory Disorders
1 clinical trials · Condition
◉ Watch Type 2 Inflammatory Disorders
| Record | Firm | Date |
|---|---|---|
| Compassionate Use of Dupilumab (NCT04776694) | Regeneron Pharmaceuticals |
Track Type 2 Inflammatory Disorders automatically
Every clearance here is in the API, with alerts when new ones post.